14-59464071-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_022571.6(GPR135):āc.1156A>Gā(p.Ile386Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 1,613,072 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022571.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR135 | NM_022571.6 | c.1156A>G | p.Ile386Val | missense_variant | 1/1 | ENST00000395116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR135 | ENST00000395116.2 | c.1156A>G | p.Ile386Val | missense_variant | 1/1 | NM_022571.6 | P1 | ||
GPR135 | ENST00000481661.1 | c.1156A>G | p.Ile386Val | missense_variant, NMD_transcript_variant | 1/7 | 1 | |||
L3HYPDH | ENST00000466522.1 | n.31-2898A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000473 AC: 72AN: 152228Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000686 AC: 17AN: 247974Hom.: 0 AF XY: 0.0000668 AC XY: 9AN XY: 134722
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1460844Hom.: 1 Cov.: 30 AF XY: 0.0000344 AC XY: 25AN XY: 726754
GnomAD4 genome AF: 0.000473 AC: 72AN: 152228Hom.: 1 Cov.: 33 AF XY: 0.000471 AC XY: 35AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.1156A>G (p.I386V) alteration is located in exon 1 (coding exon 1) of the GPR135 gene. This alteration results from a A to G substitution at nucleotide position 1156, causing the isoleucine (I) at amino acid position 386 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at